Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001181431-10-052667
Filing Date
2010-11-01
Accepted
2010-11-01 18:00:00
Documents
1
Period of Report
2010-10-13

Document Format Files

Seq Description Document Type Size
1 FORM 4/A rrd289651.html 4/A  
1 FORM 4/A rrd289651.xml 4/A 11158
  Complete submission text file 0001181431-10-052667.txt   13026
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Issuer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O TITAN PHARMACEUTICALS INC. 400 OYSTER POINT BOULEVARD, SUITE 505 SAN FRANCISCO CA 94080
Business Address
Kapp Joachim Friedrich (Reporting) CIK: 0001338543 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-27436 | Film No.: 101155919